Article
Genetic background influences susceptibility to chemotherapy-induced hematotoxicity.
The pharmacogenomics journal - 1 Apr 2018
Gatti D M, Weber S N, Goodwin N C, Lammert F, Churchill G A
Abstract excerpt
Hematotoxicity is a life-threatening side effect of many chemotherapy regimens. Although clinical factors influence patient responses, genetic factors may also play an important role. We sought to identify genomic loci that influence chemotherapy-induced hematotoxicity by dosing Diversity Outbred mice with one of three chemotherapy drugs; doxorubicin, cyclophosphamide or docetaxel. We observed that each drug had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
